Journal
AMERICAN JOURNAL OF PATHOLOGY
Volume 190, Issue 8, Pages 1584-1595Publisher
ELSEVIER SCIENCE INC
DOI: 10.1016/j.ajpath.2020.04.003
Keywords
-
Categories
Funding
- National Cancer Institute [R01CA211732, R21CA223675]
- American Cancer Society Research Scholar Award [TBE-132187]
- Department of Defense Kidney Cancer Research Program [W81XWH1910813]
- Cancer Prevention and Research Institute of Texas (CPRIT) [RR190058]
- U.S. Department of Defense (DOD) [W81XWH1910813] Funding Source: U.S. Department of Defense (DOD)
Ask authors/readers for more resources
Maintaining oxygen homeostasis is a most basic cellular process for adapting physiological oxygen variations, and its abnormality typically leads to various disorders in the human body. The key molecules of the oxygen-sensing system include the transcriptional regulator hypoxia-inducible factor (HIF), which controls a wide range of oxygen responsive target genes (eg, EPO and VEGF), certain members of the oxygen/2-oxoglutarate-dependent dioxygenase family, including the HIF proline hydroxylase (PHD, alias EGLN), and an E3 ubiquitin ligase component for HIF destruction called von Hippel-Lindau. In this review, we summarize the physiological role and highlight the pathologic function for each protein of the oxygen-sensing system. A better understanding of their molecular mechanisms of action will help uncover novel therapeutic targets and develop more effective treatment approaches for related human diseases, including cancer.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available